View in EDS HTML Full Text PDF Full Text

Optimising patient centred drug development to realise impact.

Saved in:
Bibliographic Details
Title: Optimising patient centred drug development to realise impact.
Authors: Calvert M; Centre for Patient Reported Outcomes Research, Department of Applied Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK. m.calvert@bham.ac.uk.; Birmingham Health Partners Centre for Regulatory Science and Innovation, University of Birmingham, Birmingham, UK. m.calvert@bham.ac.uk.; National Institute for Health and Care Research (NIHR) Birmingham Biomedical Research Centre, University of Birmingham, Birmingham, UK. m.calvert@bham.ac.uk.; National Institute for Health and Care Research (NIHR) Applied Research Collaboration (ARC) West Midlands, University of Birmingham, Birmingham, UK. m.calvert@bham.ac.uk.; NIHR Blood and Transplant Research Unit (BTRU) in Precision Transplant and Cellular Therapeutics, University of Birmingham, Birmingham, UK. m.calvert@bham.ac.uk., Kamudoni P; Merck KGaA, Darmstadt, Germany., Yap C; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, UK., Snyder C; Johns Hopkins Schools of Medicine and Public Health, Baltimore, MD, USA., Wilson R; Patient Member, Cancer Research Advocates Forum UK, London, UK., Aiyegbusi OL; Centre for Patient Reported Outcomes Research, Department of Applied Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK.; Birmingham Health Partners Centre for Regulatory Science and Innovation, University of Birmingham, Birmingham, UK.; National Institute for Health and Care Research (NIHR) Birmingham Biomedical Research Centre, University of Birmingham, Birmingham, UK.; National Institute for Health and Care Research (NIHR) Applied Research Collaboration (ARC) West Midlands, University of Birmingham, Birmingham, UK.; NIHR Blood and Transplant Research Unit (BTRU) in Precision Transplant and Cellular Therapeutics, University of Birmingham, Birmingham, UK.
Source: Communications medicine [Commun Med (Lond)] 2026 May 19; Vol. 6 (1). Date of Electronic Publication: 2026 May 19.
Publication Type: Journal Article
Journal Info: Publisher: Nature Portfolio Country of Publication: England NLM ID: 9918250414506676 Publication Model: Electronic Cited Medium: Internet ISSN: 2730-664X (Electronic) Linking ISSN: 2730664X NLM ISO Abbreviation: Commun Med (Lond) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42156971
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Optimising patient centred drug development to realise impact.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Calvert+M%22">Calvert M</searchLink>; Centre for Patient Reported Outcomes Research, Department of Applied Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK. m.calvert@bham.ac.uk.; Birmingham Health Partners Centre for Regulatory Science and Innovation, University of Birmingham, Birmingham, UK. m.calvert@bham.ac.uk.; National Institute for Health and Care Research (NIHR) Birmingham Biomedical Research Centre, University of Birmingham, Birmingham, UK. m.calvert@bham.ac.uk.; National Institute for Health and Care Research (NIHR) Applied Research Collaboration (ARC) West Midlands, University of Birmingham, Birmingham, UK. m.calvert@bham.ac.uk.; NIHR Blood and Transplant Research Unit (BTRU) in Precision Transplant and Cellular Therapeutics, University of Birmingham, Birmingham, UK. m.calvert@bham.ac.uk.<br /><searchLink fieldCode="AU" term="%22Kamudoni+P%22">Kamudoni P</searchLink>; Merck KGaA, Darmstadt, Germany.<br /><searchLink fieldCode="AU" term="%22Yap+C%22">Yap C</searchLink>; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, UK.<br /><searchLink fieldCode="AU" term="%22Snyder+C%22">Snyder C</searchLink>; Johns Hopkins Schools of Medicine and Public Health, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Wilson+R%22">Wilson R</searchLink>; Patient Member, Cancer Research Advocates Forum UK, London, UK.<br /><searchLink fieldCode="AU" term="%22Aiyegbusi+OL%22">Aiyegbusi OL</searchLink>; Centre for Patient Reported Outcomes Research, Department of Applied Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK.; Birmingham Health Partners Centre for Regulatory Science and Innovation, University of Birmingham, Birmingham, UK.; National Institute for Health and Care Research (NIHR) Birmingham Biomedical Research Centre, University of Birmingham, Birmingham, UK.; National Institute for Health and Care Research (NIHR) Applied Research Collaboration (ARC) West Midlands, University of Birmingham, Birmingham, UK.; NIHR Blood and Transplant Research Unit (BTRU) in Precision Transplant and Cellular Therapeutics, University of Birmingham, Birmingham, UK.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229918250414506676%22">Communications medicine</searchLink> [Commun Med (Lond)] 2026 May 19; Vol. 6 (1). <i>Date of Electronic Publication: </i>2026 May 19.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Portfolio%22">Nature Portfolio </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9918250414506676 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2730-664X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222730664X%22">2730664X </searchLink><i>NLM ISO Abbreviation: </i>Commun Med (Lond) <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42156971
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s43856-026-01634-2
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Optimising patient centred drug development to realise impact.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Calvert M
      – PersonEntity:
          Name:
            NameFull: Kamudoni P
      – PersonEntity:
          Name:
            NameFull: Yap C
      – PersonEntity:
          Name:
            NameFull: Snyder C
      – PersonEntity:
          Name:
            NameFull: Wilson R
      – PersonEntity:
          Name:
            NameFull: Aiyegbusi OL
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 19
              M: 05
              Text: 2026 May 19
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2730-664X
          Numbering:
            – Type: volume
              Value: 6
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Communications medicine
              Type: main
ResultId 1